The MarketWatch News Department was not involved in the creation of this content.-- Centanafadine is an investigational compound for the treatment of ADHD in children, adolescents ...

The Prescription Drug User Fee Act target action date for the NDA is scheduled for 24 July 2026.

New brain research could reshape our understanding of ADHD and the most common drugs that treat it.

It has long been assumed that psychostimulants help those with ADHD by acting on the brain’s attention circuitry. However, ...

Specialists and families have been taken by surprise that Southern Cross Health Insurance won't fund treatment.

From 2022 to 2024, stimulant prescriptions issued in Connecticut increased by 13.2 percent, according to data from the state.

With an expiration date still more than a year away, here's what the latest details reveal.

Women are driving soaring use of ADHD medication, experts say. Researchers from the University of Oxford highlighted a ...

Taking ADHD medication might just save your life — and not in the way you’d expect. A groundbreaking study involving nearly 150,000 people reveals that those who take medication for their ADHD face ...

UK had highest relative increase of five countries in study, with 20-fold rise in proportion of women over 25 using it ...

Long-term methylphenidate use in childhood links to higher adult BMI and slightly shorter height, underscoring the need for ...

The use of medication to treat Attention-Deficit Hyperactivity Disorder (ADHD) has risen sharply in the UK, largely due to ...